search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Dystrophic pathways in human hair follicles after chemotherapy with or without scalp cooling


- candidate number25501
- NTR NumberNTR6204
- ISRCTNISRCTN no longer applicable
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR3-nov-2016
- Secondary IDsM016-044  METC Noord-Holland
- Public TitleDystrophic pathways in human hair follicles after chemotherapy with or without scalp cooling
- Scientific TitleDystrophic pathways in human hair follicles after chemotherapy with or without scalp cooling
- ACRONYMPATH-2
- hypothesisDamage response pathways can possibly explain the working mechanism of scalp cooling
- Healt Condition(s) or Problem(s) studiedChemotherapy, Scalp cooling
- Inclusion criteria- Patients with cancer
- Indication for at least one cycle docetaxel or paclitaxel
- Age 18 years or more
- Written informed consent
- Exclusion criteria- Not applicable
- mec approval receivedyes
- multicenter trialno
- randomisedno
- groupParallel
- TypeSingle arm
- Studytypeobservational
- planned startdate 16-mrt-2017
- planned closingdate31-dec-2018
- Target number of participants10
- InterventionsWhy scalp cooling is effective in one patient but not in another remains unclear. As the rationale for the use of scalp hypothermia has not been completely elucidated, the cooling protocol may not be optimal. To understand the underlying pathobiology of CIA, we investigate molecular damage-response pathways in hair follicles after chemotherapy and the influence of scalp cooling on these molecular pathways.
- Primary outcomeExpression of damage-response pathways
- Secondary outcomeNA
- TimepointsHairs will be collected at six different time points T=0 acts as a control time point as no chemotherapy is administered.

Hair sample collection time points:
t=0 (before treatment with chemotherapy)
t=1 (one day after chemotherapy)
t=2 (two days after chemotherapy)
t=3 (three days after chemotheray)
t=5 (five days after chemotherapy)
t=7 (seven days after chemotherapy)
- Trial web siteNA
- statusopen: patient inclusion
- CONTACT FOR PUBLIC QUERIESMSc. M.M.C. Komen
- CONTACT for SCIENTIFIC QUERIESMSc. M.M.C. Komen
- Sponsor/Initiator Noordwest Ziekenhuisgroep
- Funding
(Source(s) of Monetary or Material Support)
Noordwest Ziekenhuisgroep
- PublicationsNA
- Brief summaryChemotherapy acts on rapidly growing cells, including hair follicles. Chemotherapy-induced shedding of hairs usually occurs 714 days after infusion. For patients, chemotherapy-induced alopecia (CIA) is one of the most distressing side-effects of treatment. Scalp cooling can prevent or minimise CIA. The rationale for the use of scalp hypothermia has not been completely elucidated and may depend on p53, Caspase-3 and Bax/bcl2. Suppression of these enzymes is possibly one of the underlying mechanisms influencing the effect of scalp cooling.
The objective of this study is to determine the dystrophic pathway factors involved in chemotherapy induced-apoptosis (programmed cell death) in the hair follicle after chemotherapy. The study will be conducted in the out-patient chemotherapy clinic of the department of Internal Medicine of the Northwest Clinics.
Study population: The study will enroll ten patients with breast cancer (with/ without scalp cooling) evaluable for one cycle of intravenous administered taxane containing chemotherapy.
- Main changes (audit trail)
- RECORD3-nov-2016 - 16-nov-2017


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl